Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT01816971 · COMPLETED
Trial details
- NCT number
- NCT01816971
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2018-04-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.